Stock research
AEON AEON Biopharma, Inc.
Healthcare • Biotechnology
AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key investigational...…
AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key investigational products is ABP-450, a 900 kDa botulinum toxin complex, which is being advanced for therapeutic use in conditions such as migraine, cervical dystonia, and gastroparesis. The entity, originally known as ALPHAEON Corporation, adopted the name AEON Biopharma, Inc. in December 2019. Established in 2012, the company maintains its principal operations from Newport Beach, California.
5Y change
-99.96%
Range high
$1,172.88
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in AEON?
Price
Showing 5Y history. Source: FMP historical price full.
- Prev Close
- $0.29
- Day High
- $0.30
- Day Low
- $0.28
- 52w High
- $1.45
- 52w Low
- $0.22
- Volume
- 743,928
- Avg Volume
- Beta
- 0.607
* TTM/most recent where available
Company
- Ticker
- AEON
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- US
- CEO
- Robert Bancroft
- Employees
- 8
- Website
- www.aeonbiopharma.com
Key Metrics
- Market Cap
- 3.49M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).